Candel Therapeutics Stock Target Price and Analyst Consensus

CADL Stock  USD 4.84  0.20  3.97%   
The current analyst and expert consensus on Candel Therapeutics is Strong Sell, with no strong buy opinions. The current projected Candel Therapeutics target price consensus is 9.50 with 0 analyst opinions. Check out Macroaxis Advice on Candel Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.
The most common way Candel Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Candel Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Candel Therapeutics. We encourage you to use your own analysis of Candel Therapeutics to validate this buy or sell advice. Candel Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Candel Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 4.6641.
Lowest Forecast
8.65
Highest Forecast
10.55
Target Price
9.5
Gross Profit is expected to rise to about (22.8 M) this year. The value of Pretax Profit Margin is estimated to slide to -181.55. At this time, Candel Therapeutics' Accounts Payable is quite stable compared to the past year. Cash is expected to rise to about 50.2 M this year, although the value of Other Liabilities will most likely fall to about 2.2 M.
  
It's important to approach Candel Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Candel Therapeutics price targets

Candel Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Candel Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Candel Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Candel Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Candel Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Candel Therapeutics is a key component of Candel Therapeutics valuation and have some predictive power on the future returns of a Candel Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Candel Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.064.779.48
Details
Intrinsic
Valuation
LowRealHigh
1.205.9110.62
Details
Naive
Forecast
LowNextHigh
0.094.559.26
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Casinos Idea
Casinos
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested over 60 shares
Impulse Idea
Impulse
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Momentum Idea
Momentum
Invested over 40 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
When determining whether Candel Therapeutics is a strong investment it is important to analyze Candel Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Candel Therapeutics' future performance. For an informed investment choice regarding Candel Stock, refer to the following important reports:
Check out Macroaxis Advice on Candel Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.